Rosen Law Firm Urges QuidelOrtho Corporation Investors to Seek Legal Advice Ahead of Imminent Deadline

New York-based Rosen Law Firm, recognized for its commitment to representing investor rights, has issued a reminder to all individuals or institutions who acquired QuidelOrtho Corporation QDEL common stock during the period from February 18, 2022, to April 1, 2024. The firm is emphasizing the significance of the approaching June 11, 2024 deadline to be appointed as lead plaintiff in the securities class-action lawsuit which has been filed against QuidelOrtho.

Background of QuidelOrtho Corporation

QuidelOrtho Corporation, carrying the stock symbol QDEL, operates in the healthcare sector with a specialized focus on developing and marketing diagnostic testing solutions. With a diverse portfolio covering infectious disease, cardiology, thyroid health, and more, the company headquartered in San Diego, California caters to the global market with its innovative healthcare products.

Details of the Class Action Suit

The lawsuit concerns investors who procured the common stock of QuidelOrtho during the aforementioned class period. Les Rosen, as the lead counsel of the firm, stresses the importance of the deadline for shareholders to partake in the lawsuit and potentially recuperate damages stemming from alleged violations of federal securities laws. Rosen Law Firm’s experience in similar lawsuits forebodes thorough legal scrutiny to safeguard investor interests.

Impact and Implications for Investors

For investors of QuidelOrtho Corporation QDEL, the outcome of the class-action suit could be substantial. Aligning with a seasoned legal firm can maximize the opportunities for a favorable resolution, potentially mitigating losses incurred. As such, Rosen Law Firm is positioned as a trusted counselor, advocating for investors’ rights and guiding them through the complexities of securities class actions.

RosenLawFirm, QuidelOrtho, QDEL